Start / PharmaTalkRadio / Utilizing a device platform technology across multiple therapeutic categories

PharmaTalkRadio

Utilizing a Device Platform Technology across Multiple Therapeutic Categories

36 min • 7 juni 2018

Panel: Utilizing a Device Platform Technology across Multiple Therapeutic Categories Most pharma and biotech companies realize the need and benefit of having a platform device technology. The challenge then becomes figuring out how to utilize the device to deliver different types of drugs for various indications such as rheumatoid arthritis, cancer, and rare diseases. Moderator: Paul Jansen Former Associate VP Sanofi and Board Member and Senior Advisor, Haselmeier Panelists: Donna French, PhD VP Drug Delivery and Device Development, MedImmune Michael Graffeo, MBA VP Business Development, Drug Delivery Insulet Rajan Patel CEO, io Life science Srini Sridharan, PhD Group Director, Materials Science and Engineering, BMS

Senaste avsnitt

Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy

14 augusti | 29 min

De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing

12 augusti | 28 min

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

12 augusti | 28 min

Directors' Talk DPHARM 2025 - AI Sessions; Part III

25 juli | 6 min

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

25 juli | 20 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00